ID   Y3-Ag 1.2.3
AC   CVCL_4342
SY   Y3.AG.1.2.3; Y3-Ag1.2.3; Y3-Ag1,2,3; Y3Ag1.2.3; Y-3-Ag 1.2.3; 210-RC Y3-Ag 1,2,3; 210RCY3-Ag1.2.3; 210RCY3-Ag123; Y3-Ag123; Y3; Y3M
DR   CLO; CLO_0009706
DR   CLO; CLO_0009707
DR   CLDB; cl4794
DR   CLDB; cl4795
DR   ATCC; CRL-1631
DR   CCRID; 3101RATTCR10
DR   CLS; 305207
DR   ECACC; 85110502
DR   JCRB; JCRB9091
DR   TKG; TKG 0283
DR   Wikidata; Q54995192
RX   CelloPub=CLPUB00609;
RX   PubMed=310519;
RX   PubMed=22358559;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Breed/subspecies: LOU/C.
DI   NCIt; C125416; Rat plasma cell myeloma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
RX   CelloPub=CLPUB00609;
RA   Digneffe C., Cormont F., Platteau B., Bazin H.;
RT   "Fusion cell lines.";
RL   (In) Rat hybridomas and rat monoclonal antibodies; Bazin H. (eds.); pp.69-74; CRC Press; Boca Raton (1990).
//
RX   PubMed=310519; DOI=10.1038/277131a0;
RA   Galfre G., Milstein C., Wright B.;
RT   "Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse
RT   IgG.";
RL   Nature 277:131-133(1979).
//
RX   PubMed=22358559; DOI=10.1007/BF00749657;
RA   Keen M.J.;
RT   "The culture of rat myeloma and rat hybridoma cells in a protein-free
RT   medium.";
RL   Cytotechnology 17:193-202(1995).
//